Jeffrey Wager

Jeffrey Wager is the current CEO at Proterris. Jeffrey has also previously served as the co-founder, chairman, and CEO at EnBiotix, Inc. from January 2012 to January 2022. Prior to that, they were the president and CEO, as well as a member of the board of directors, at Artisan Pharma, Inc. from July 2006 to December 2009. Wager has also worked as a senior associate at Medical Science Partners from October 1995 to January 2000 and as the executive director of business development for the life sciences group at Kasho Company Limited from January 1991 to October 1995.

Jeffrey Wager has an MBA from The University of Chicago Booth School of Business and an M.D. from Rush Medical College of Rush University Medical Center.

Joseph Wager - VP, Business Development, Kourosh Saeb-Parsy - Acting Chief Medical Officer, and Benjamin Perrone - Director, BD & Finance report to Jeffrey Wager.